
Kenya has made remarkable progress in the fight against tuberculosis, cutting deaths by more than half in a decade. But this achievement must not breed complacency.
The latest World Health Organisation report exposes a worrying vulnerability: declining funding and falling diagnoses could undermine years of hard-won gains.
The figures are sobering. Kenya achieved the first milestones of the WHO End TB Strategy two years ahead of schedule, but failed to meet the more ambitious 2025 targets.
More troubling is that 90,900 patients were diagnosed and started treatment in 2025, representing only 81 per cent of the estimated number of people who developed the disease.
A decline in reported cases is not necessarily evidence that TB is retreating. It could mean fewer people are being screened, tested and diagnosed, leaving infections undetected and untreated.
The estimated Sh15.6 billion funding gap facing Kenya’s TB programme in 2026 should therefore alarm policymakers. Government must increase domestic investment, protect screening and treatment services, and ensure donor funding shortfalls do not interrupt care.
TB is preventable and treatable. Allowing financial constraints to reverse progress would be a costly failure. Kenya must protect the gains and pursue the unfinished fight with urgency.